The biotechnology sector continues to be a focal point for investors seeking groundbreaking innovations and substantial growth opportunities. As we progress through 2025, several biotech companies are preparing to make their debut on the public markets. This article provides an overview of the top biotech IPOs to watch this year, highlighting their key developments, financial health, and potential market impact.
1. Metsera, Inc. Metsera, founded in 2022 by ARCH Venture Partners and Population Health Partners, has rapidly positioned itself as a notable player in the weight-loss therapeutics arena.